Pharmacology
Resource Center
Featured
03/31/2024
Jeffrey A. Sparks, MD MMSc
Jeffrey A. Sparks, MD MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
03/25/2024
Brenden P. Lucey, MD, MSCI
Brenden P. Lucey, MD, MSCI
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024
03/23/2024
Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
03/23/2024
Interactive Features
03/02/2024
SNRIs are commonly prescribed to treat depression. W. Clay Jackson, MD, DipTh, asks if you how serotonin-norepinephrine reuptake inhibitors are used to reduce pain.
03/02/2024
03/02/2024
The American Heart Association released a scientific statement on the benefits and risks of using complementary and alternative medicines that included suggestions on how to discuss these medications with...
03/02/2024
12/16/2023
A New York court makes the distinction between medical malpractice and ordinary negligence in a case involving a doctor who wrote an illegible prescription.
12/16/2023
10/30/2023
A California physician was sentenced to more than a decade in prison for conspiring with a pharmacist to illegally distribute controlled substances. Should the pharmacist receive a similar sentence?
10/30/2023
11/12/2021
How well do you know the Endocrine Society's clinical practice guideline for the pharmacological management of osteoporosis in postmenopausal women? Test your knowledge in our latest quiz.
11/12/2021
Clinical Insights
03/31/2024
Jeffrey A. Sparks, MD MMSc
Jeffrey A. Sparks, MD MMSc
In this video, Jeffrey A. Sparks, MD, MMSc, discusses his study that evaluated the outcomes of patients with pre-existing rheumatoid arthritis (RA) who initiated immune checkpoint inhibitors for cancer, if...
03/31/2024
03/25/2024
Brenden P. Lucey, MD, MSCI
Brenden P. Lucey, MD, MSCI
In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...
03/25/2024
03/23/2024
Based on findings from the Phase 3 A DUE study, Janssen Research & Development, LLC recently submitted a New Drug Application to the FDA seeking approval of an investigational once-daily, single-tablet...
03/23/2024
Video: Multidisciplinary Roundtable
Video: Multidisciplinary Roundtable
03/09/2024
In this video, cardiologists Seth Martin, MD, MHS, and Jessica Golbus, MD, speak with Sarah Riley, MSN, CRNP, CHFN, and Michael Dorsch, PharmD, MS, in a roundtable discussion on the role of a...
03/09/2024
02/20/2024
Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...
02/20/2024